Form 8.5 (EPT/RI)- Dechra Pharmaceuticals plc

Morgan Stanley & Co. Int'l plc
05 October 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Dechra Pharmaceuticals plc

(c) Name of the party to the offer with which exempt principal trader is connected:

EQT (EQT X EUR SCSp and EQT X USD SCSp)

(d) Date dealing undertaken:

04 October 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

     If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

SALES

130,396

37.9165 GBP

37.7820 GBP

1p ordinary

PURCHASES

70,361

37.9204 GBP

37.7915 GBP

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

CFD

increasing a long position

332

37.7820 GBP

1p ordinary

CFD

increasing a long position

540

37.7989 GBP

1p ordinary

CFD

increasing a long position

185

37.8136 GBP

1p ordinary

CFD

increasing a long position

220

37.8230 GBP

1p ordinary

CFD

increasing a long position

1,390

37.8280 GBP

1p ordinary

CFD

increasing a long position

525

37.8366 GBP

1p ordinary

CFD

increasing a long position

2,042

37.8800 GBP

1p ordinary

CFD

increasing a long position

88

37.8800 GBP

1p ordinary

CFD

increasing a long position

23,696

37.8800 GBP

1p ordinary

CFD

increasing a short position

3,119

37.8695 GBP

1p ordinary

CFD

increasing a short position

313

37.8695 GBP

1p ordinary

CFD

increasing a short position

2,520

37.8780 GBP

1p ordinary

CFD

increasing a short position

3,046

37.8780 GBP

1p ordinary

CFD

reducing a long position

1,840

37.8419 GBP

1p ordinary

CFD

reducing a long position

473

37.8569 GBP

1p ordinary

CFD

reducing a long position

7,365

37.8642 GBP

1p ordinary

CFD

reducing a long position

3,844

37.8800 GBP

1p ordinary

CFD

reducing a long position

24

37.8800 GBP

1p ordinary

CFD

reducing a long position

46

37.8800 GBP

1p ordinary

CFD

reducing a long position

30

37.8800 GBP

1p ordinary

CFD

reducing a long position

193

37.8932 GBP

1p ordinary

CFD

reducing a short position

63

37.8326 GBP

1p ordinary

CFD

reducing a short position

801

37.8326 GBP

1p ordinary

CFD

reducing a short position

2,061

37.8326 GBP

1p ordinary

CFD

reducing a short position

897

37.8326 GBP

1p ordinary

CFD

reducing a short position

41,099

37.8340 GBP

1p ordinary

CFD

reducing a short position

19,662

37.8649 GBP

1p ordinary

CFD

reducing a short position

4

37.8650 GBP

1p ordinary

CFD

reducing a short position

2,279

37.8800 GBP

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

Date of disclosure:

05 October 2023

Contact name:

Craig Horsley

Telephone number:

+44 141 245-7736

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings